2026-09-30 · 1 篇
吞咽困难在鼻咽癌调强放疗后幸存者抑郁、焦虑及症状群中的作用：基于横断面研究的潜在剖面与中介分析
The Role of Dysphagia in Depression, Anxiety, and Symptom Clusters Among Nasopharyngeal Carcinoma Survivors After Intensity-Modulated Radiotherapy: A Latent Profile and Mediation Analysis Based on a Cross-Sectional Study.
2026-09-29 · 1 篇
诊断至治疗间隔与放疗间隔对鼻咽癌生存的个体及累积影响
Individual and Cumulative Impacts of Diagnosis-to-Treatment Interval and Radiotherapy Interval on Survival in Nasopharyngeal Cancer.
2026-09-28 · 1 篇
鼻咽癌接受调强放疗与三维适形放疗技术的治疗结局：一个发展中国家的单中心经验
Treatment Outcomes in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy Versus 3D-Conformal Radiotherapy Techniques: A Single-Center Experience in a Developing Country.
2026-09-25 · 2 篇
鼻咽癌选择性淋巴结照射剂量降至45 Gy：一项具有5年结局的大型队列研究
De-escalating elective nodal irradiation dose to 45 Gy in nasopharyngeal carcinoma: A large-cohort study with 5-year outcomes.
鼻咽癌表型共病网络分析：基于医院出院记录的多中心研究
Phenotypic comorbidity network analysis of nasopharyngeal carcinoma: a multicenter study based on hospital discharge records.
2026-09-24 · 1 篇
HARP（血红蛋白-白蛋白-C反应蛋白）指数：一种用于局部晚期鼻咽癌连续预后建模的生物学设计复合生物标志物
The HARP (Hemoglobin-Albumin-C-Reactive Protein) Index: A Biologically Designed Composite Biomarker for Continuous Prognostic Modeling in Locally Advanced Nasopharyngeal Carcinoma.
2026-09-23 · 1 篇
鼻咽癌GTV分割中体积精度与解剖精度的影响：一项基于共识指南的研究
Impacts of volumetric vs. anatomical accuracies in GTV segmentation for nasopharyngeal carcinoma: a consensus-guideline-based study.
2026-09-22 · 2 篇
专家中心治疗罕见头颈癌的诊疗模式与质量：欧洲罕见成人实体癌参考网络（EURACAN）登记处的经验。
Pattern and quality of care for rare head and neck cancers treated in expert centres: the experience of the registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN).
鼻咽癌中基于CT和MRI的影像学结外扩展分级的信度与效度
Reliability and Validity of Imaging-derived Extranodal Extension Grading Using CT and MRI in Nasopharyngeal Carcinoma.
2026-09-21 · 1 篇
接受手术治疗的头颈癌住院患者的营养知识、态度和实践（KAP）与GLIM定义营养不良：一项中国横断面研究。
Nutritional knowledge, attitudes, and practices (KAP) and GLIM-defined malnutrition in hospitalized head and neck cancer patients receiving surgical treatment: A cross-sectional study in china.
2026-09-20 · 1 篇
非转移性鼻咽癌第9版TNM分期系统的验证：来自高发地区的多中心回顾性分析
Validation of the 9th Edition of the Tumor-Node-Metastasis Staging System for Non-Metastatic Nasopharyngeal Carcinoma: A Multicenter Retrospective Analysis From High-Incidence Regions.
2026-09-19 · 3 篇
放疗后鼻咽癌幸存者椎动脉假性动脉瘤伴复发性后循环短暂性脑缺血发作：一例病例报告
Vertebral artery pseudoaneurysm with recurrent posterior circulation transient ischemic attacks in a post-radiotherapy nasopharyngeal carcinoma survivor: a case report.
鼻咽癌患者计划靶区六维与三维误差校正的比较。
Comparison of Six- and Three-Dimensional Error Corrections for the Planning Target Volume in Patients With Nasopharyngeal Cancer.
老年营养风险指数与肌少症整合用于接受同步放化疗的鼻咽癌预后评估：一项大规模长期回顾性研究
Integration of geriatric nutritional risk index and sarcopenia for prognostic assessment in nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a large-scale long-term retrospective study.
2026-09-18 · 2 篇
基于第9版AJCC/UICC TNM分期系统在中国非流行区对鼻咽癌N分期的验证与优化：一项多中心队列研究
Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study.
诱导化疗前后肿瘤体积在局部晚期鼻咽癌中的预后价值比较
Comparative Prognostic Value of Pre- and Post-Induction Chemotherapy Tumor Volumes in Locoregionally Advanced Nasopharyngeal Carcinoma.
2026-09-16 · 2 篇
低发病率人群中鼻咽癌放疗后的失败模式：一项DAHANCA研究。
Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low-Incidence Population: A DAHANCA Study.
为鼻咽癌患者开发营养自我管理角色：基于福格行为模型的定性研究。
Developing personas for nutritional self-management in nasopharyngeal carcinoma patients: a qualitative study based on the Fogg Behavior Model.
2026-09-15 · 2 篇
免疫炎症和营养指标在局部区域晚期鼻咽癌中的预后意义。
Prognostic significance of immune-inflammatory and nutritional indicators in locoregionally advanced nasopharyngeal carcinoma.
评估非地方性儿童鼻咽癌治疗前EB病毒水平的预后相关性
Evaluating the Prognostic Relevance of Pre-Treatment Epstein-Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal Carcinoma.